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Giant Eyes in Xenopus laevis
by Overexpression of XOptx2
eyes (Shen and Mardon, 1997; Halder et al., 1998). In
spite of structural and embryological differences, the
development of the Drosophila and vertebrate eye re-
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University of Cambridge quires the actions of highly conserved transcription fac-
tors. Clear examples are Pax6 (ey), Six3 (so), Rx1 (DRx),Cambridge, CB2 3DY
United Kingdom and Eya (eya) (reviewed in Jean et al., 1998). Moreover,
inactivation of Pax6 or Rx1 in mice results in animals²Department of Oncology
University of Cambridge with reduced or no eyes, while ectopic Rx1 expression
in Xenopus laevis leads to partial duplication of the eyeCambridge, CB3 2QQ
United Kingdom and extra pigment epithelial tissue (Quiring et al., 1994;
Mathers et al., 1997), and overexpression of Six3 in fish³Molecular Neurobiology Laboratory
The Salk Institute for Biological Studies leads to ectopic expression of retinal markers (Oliver et
al., 1996; Loosli et al., 1999). Clearly, intrinsic factorsSan Diego, California 92186-5800
that regulate the proliferation of cells expressing these
important eye determinant genes would have dramatic
effects on eye size.Summary
Optx2, a new member of the Six/sine oculis (Six/so)
family of homeobox-containing genes, has recentlyOverexpression of XOptx2, a homeodomain-containing
transcription factor expressed in the Xenopus embry- been cloned in chicken and in mouse (Toy et al., 1998).
In this paper, we describe the isolation, characterization,onic eye field, results in a dramatic increase in eye
size. An XOptx2-Engrailed repressor gives a similar and overexpression phenotype of the Xenopus Optx2
homolog (XOptx2). We also interfered with its normalphenotype, while an XOptx2-VP16 activator reduces eye
size. XOptx2 stimulates bromodeoxyuridine incorpo- function. Lastly, we explored a synergistic action of Pax6
and XOptx2 in the regulation of vertebrate eye size. Ourration, and XOptx2-induced eye enlargement is depen-
dent on cellular proliferation. Moreover, retinoblasts results suggest that XOptx2 is an intrinsic repressor that
induces cell proliferation in the eye field and thus hastransfected with XOptx2 produce clones of cells ap-
proximately twice as large as control clones. Pax6, a profound effect on eye size.
which does not increase eye size alone, acts synergis-
tically with XOptx2. Our results suggest that XOptx2, Results
in combination with other genes expressed in the eye
field, is crucially involved in the proliferative state of Isolation and Molecular Analysis
retinoblasts and thereby the size of the eye. of a Xenopus Optx2
We amplified a fragment of the Xenopus Optx2 cDNA
from stage 18 eyecup RNA using degenerate primersIntroduction
and RT-PCR. This partial cDNA was used as a probe to
screen a Xenopus cDNA library to isolate several XOptx2Transplantation of organ primordia between embryos
of large and small amphibian species has shown that cDNAs. Finally, we used 59-RACE to isolate additional
59 sequences not present in the largest isolated cDNA.organ size is often an intrinsic property of the primor-
dium (reviewed in Twitty, 1940; Harris, 1979). When optic The Xenopus Optx2 cDNA contains an open reading
frame of 735 nucleotides (Figure 1A). Multiple in-framevesicles were transplanted between the large-eyed Am-
bystoma tigrinum and the small-eyed Ambystoma punc- stop codons are present prior to the initiation codon
and following the termination codon. A consensus sitetatum, the tigrinum eye became disproportionately large
for its punctatum host, while the grafted punctatum eye- for polyadenylation is also present at position 1563.
Three features of the predicted amino acid sequence ofbud preserved its small size in spite of the fact that it
was nourished by a much larger and rapidly growing the cDNA identify it as a member of the Six/so family
and a likely Xenopus ortholog of Optx2: the Six domain,host (Stone, 1930; reviewed in Twitty, 1955).
Although the factors that control eye size are largely the homeobox domain, and the position of the initiation
methionine. The Six domain of mouse Optx2 sharesunknown, our understanding of vertebrate eye genesis
has benefited greatly from the study of several Drosoph- more sequence similarity with the Xenopus Optx2 than
any reported mouse Six/so family member (Figure 1B).ila melanogaster transcription factors. Inactivation of
eyeless (ey), sine oculis (so), eyes absent (eya), or dachs- The XOptx2 homeobox domain is also more similar to
the corresponding region of Optx2 proteins than to thehund (dac) results in flies with severely reduced or no
eyes (Bonini et al., 1993; Cheyette et al., 1994; Mardon homeodomain of any other Six protein (Figures 1B and
1C). A characteristic distinction between the Six3 andet al., 1994; Quiring et al., 1994), and ectopic expression
of some of these genes induces the formation of ectopic Optx2 proteins is the length of the pre-Six domain re-
gion. All known Optx2 proteins are smaller at the amino
terminus than all known Six3 proteins. These results§ To whom correspondence should be addressed (e-mail: harris@
indicate that the isolated cDNA is a Xenopus orthologmole.bio.cam.ac.uk).
‖ These authors contributed equally to this work. of Optx2.
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Expression Patterns of XOptx2 in the Developing Xenopus embryos. Neither b-gal nor GFP affects eye
development. However, when XOptx2 RNA was injectedEmbryo and during Eye Formation
XOptx2 mRNA expression is first detected in stage 14 into embryos, we observed an obvious enlargement of
the eye on the injected side (Figure 3). This phenotypeembryos (not shown). At stage 15, XOptx2 is detected
as a single band of expression at the most anterior edge was detected in embryos injected with 5 pg of XOptx2
RNA and was maximal in embryos injected with betweenof the developing neural plate (Figure 2A). At approxi-
mately stage 17, expression extends laterally (Figure 7.5 and 12.5 pg. On average, 10 pg of XOptx2 increased
eye volume by an impressive 70%, although it was not2B). By neural groove stage (stage 18), this single band
of expression separates into two distinct regions consis- uncommon to see eyes twice as large as normal. The
minimum dosage required to observe an increase in eyetent with the location of the eye fields (Figure 2C). As
the protrusion of the eyes begins to become distinct size varied from clutch to clutch of embryos, but the
effect was always dose dependentÐinducing larger(stage 20 to 22), XOptx2 expression appears restricted
to the eyes (Figures 2D and 2E). At stage 25, XOptx2 is eyes at higher doses. Because we used the uninjected
side of the embryo as a control, we were interested toalso detected in the pineal gland primordia and the ven-
tral forebrain (Figure 2F). Expression continues to be know whether the relative increase in the size of the eye
on the XOptx2-overexpressing side was caused by thedetected in the eyes, the maturing pineal gland (not
shown), and the ventral forebrain of tailbud embryos unequal separation of the eye fields. Therefore, we com-
pared the average size of the control eye of XOptx2-(Figure 2G).
In sections of Xenopus embryos after neural tube for- injected embryos to that of age-matched controls (unin-
jected or tracer injected) and found they were identicalmation, XOptx2 expression is detected in the protruding
primary optic vesicle (Figure 2H). By stage 24, XOptx2 in size (not shown). By visual inspection, developing
embryos showed no obvious abnormalities until approx-expression is strong in the developing ventral dienceph-
alon, optic stalk, and the cells of the optic vesicle (Figure imately stage 22, when the eye bulge on the injected
side was often distinctly larger. The earliest stage at2I). As the vesicle invaginates to form the optic cup
(stage 28), XOptx2 expression remains strong in the which the enlarged eye phenotype could be quantitated
in living embryos was stage 29/30, when the pigmenta-developing retina but is not detected in the thickening
ectodermal lens placode (Figures 2J and 2K). XOptx2 is tion of the eye begins and the outline of the eye diameter
is distinct. By stage 35/36, the pigmentation patterndetected in the developing neural retina through stage
33/34 (Figure 2K). After stage 33/34, expression begins of the eye on the injected side was often similar to a
downward-turned horseshoe (luck running out) ratherto diminish in the region immediately adjacent to the
developing pigmented epithelium that will form the outer than the typical doughnut-shaped pigmentation of the
mature eye (Figures 3A and 3B). The optic fissure didnuclear (photoreceptor) layer. To correlate the genera-
tion of photoreceptors with the loss of XOptx2 expres- not close properly, which did not allow for the proper
formation of the pigmentation on the ventral side of thesion, we costained Xenopus retina to detect XOptx2
RNA and rhodopsin. By stage 41, rhodopsin is strongly eye (see Figure 4A).
Although the lens was enlarged on the injected sideexpressed in the photoreceptor layer (Figure 2M), where
XOptx2 expression is not detected (Figure 2L). Con- (by 22%, n 5 5), its diameter remained proportional to
eye diameter (lens/eye diameter ratio is 0.27 in XOptx2-trasting patterns in XOptx2 and rhodopsin expression
are also evident in the ventral retina, where cellular dif- overexpressing eyes and 0.28 in controls). This is consis-
tent with work involving cross-species transplantation offerentiation is delayed relative to the dorsal retina (Fig-
ures 2L and 2M). In this region, and in the continuously optic cups in salamander embryos, which demonstrated
that lens size is far less autonomous than eye size (Rot-proliferating ciliary marginal zone (CMZ), XOptx2 ex-
pression is maintained. mann, 1939, 1940).
In mild cases of eye enlargement, eyes overexpress-
ing XOptx2 had the same characteristic layering as theOverexpression of XOptx2 Results in a
Dose-Dependent Enlargement mature eye (Figures 3C and 3D). However, ectopic pig-
ment was often detected in the enlarged eye and wasof the Eye (and Brain)
We injected synthetic XOptx2 RNA with a tracer con- sometimes surrounded by a rosette of photoreceptors
(not shown). In extreme cases of eye enlargement, fold-struct (either b-galactosidase [b-gal] or green fluores-
cent protein [GFP]) into one blastomere of 2-cell stage ing of the neural retina was observed (Figures 3E and
Figure 1. Sequence and Structure of Xenopus Optx2
(A) Xenopus Optx2 nucleotide and predicted amino acid sequence. In-frame stop codons are shown in boldface. The double underlined
nucleotide sequence is a putative polyadenylation signal. The Six and homeobox domains are underlined and double underlined, respectively.
The Xenopus Optx2 nucleotide sequence has been deposited into the GenBank database under accession number AF081352.
(B) Schematic comparison of the predicted amino acid sequences for Xenopus Optx2 (XOptx2), chicken Optx2 (COptx2), mouse Optx2
(MOptx2), Drosophila Optix, chicken Six3 (CSix3), mouse Six3 (MSix3), and Drosophila (so) proteins. The percent similarity of the Six domains
and homeodomains to the corresponding regions in the Xenopus protein is shown. Overall sequence similarity with the Xenopus protein is
shown to the right of the sequence name.
(C) Expanded view of homeobox domain comparing the primary amino acid sequence of the six/sine oculis family members. Alpha helixes,
conserved residues thought to contact the phosphate DNA backbone (filled circles), and the conserved lysine at position 50 (asterisk) are
noted. GenBank accession numbers are AF050131 (COptx2), AF050130 (MOptx2), AF050132 (Optix), Y15106 (CSix3), X90871 (MSix3), L31626
(so), X80339 (MSix1), D83147 (MSix2), D50416 (MSix4), and D83146 (MSix5).
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the neural retina (Figure 3F). Similar results were ob-
served with markers specific for cone photoreceptors
and retinal ganglion cells (not shown). The optic fissure
was often expanded, and the ventral lumen of the brain
was bifurcated and contiguous with the eye (Figure 3G).
Retinal markers and retinal cells were also detected in
the ventral forebrain region. This is clearly illustrated by
the presence of rod photoreceptors in the track leading
from the enlarged retina to the ventral forebrain region
(Figure 3H).
When the dose of XOptx2 was increased beyond 10
pg, the size of the brain also increased. At low doses,
the brain was slightly enlarged near the eye (Figures
4A and 4B). Pigment was sometimes detected in this
enlarged brain (Figure 4B). We did not detect the expres-
sion of retinal markers (including rhodopsin) in the dorsal
brain. This is in contrast to what was observed in the
ventral brain region and within the retina (Figures 3C
and 3H). Injection of 15 pg or more of XOptx2 RNA
induced significant enlargement of the brain (Figure 4C).
We confirmed that the extra tissue was of neural charac-
ter by staining sections of these embryos with the neural
marker b-tubulin (Figure 4E). When 20 pg of XOptx2 was
injected, approximately 50% of the injected embryos
developed enlarged brains; the majority of the remaining
embryos developed enlarged eyes. By stage 35/36,
when the eye pigment would normally be evident in
intact embryos, pigment was either completely absent
or only the dorsal portion of the eye was visible. The
eye on the injected side of enlarged brain embryos was
often rotated out of its normal plane or displaced into the
body of the animal due to the presence of the additional
neural tissue (Figure 4E).
Injection of RNA into ventral blastomeres at the 4-cell
stage did not result in any detectable phenotype, indi-
cating that dorsal expression of XOptx2 was required for
Figure 2. Expression Patterns of XOptx2 during Eye and Embryonic these effects. In sectioned animals, cell counts showed
Development
there was no evidence of somite or epidermis expansion
(A±C), (F), and (G) are anterior views with dorsal (d) to the top, while
even when XOptx2 was expressed in these regions (data(D) and (E) are lateral and dorsal views of the same embryo with
not shown). However, all neural tissue, including retina,anterior (a) to the right. In (F), XOptx2 is detected in the pineal gland
brain, spinal cord, and the optic vesicle, exhibited anprimordia (arrowhead) and the ventral forebrain (arrow) as well as
the eyes. In (G), the brown area is the pigmented cement gland. increase in cell number on the injected side, from 20%
(H±M) Expression patterns on sections of XOptx2 during eye devel- to 45%, depending on the injected dose of XOptx2. Of
opment. (H±K) XOptx2 is expressed in the ventral forebrain/dien- these, the eye was the most sensitive tissue to low
cephalon (Dien), optic vesicle (ov), optic cup (oc), neural retina (nr),
doses. XOptx2's neural specific effect, combined withand the optic stalk (os) but is undetectable in the ectoderm (ect),
the fact that it is expressed primarily in the developingthe lens placode (lp), and the lens vesicle (lv). Sections of stage 41
eye and that this tissue is particularly sensitive to it,eyes (L and M) were costained to detect XOptx2 (blue) and rhodopsin
(red) expression. XOptx2 is detected in the ganglion cell (gcl) and indicates that this is where XOptx2 normally acts.
inner nuclear cell (inl) layers but is absent from the photoreceptor
(pr) layer. In (L) and (M), both the immature section of the ventral
retina (arrowhead) and the ciliary marginal zone (cmz) express
Overexpression of XOptx2 Increases the SizeXOptx2. The nonspecific signal in stage 41 section (M) is autofluores-
of the Eye Fieldcence of the lens (l). Additional abbreviations: anr, anterior neural
An increase in eye size may ensue from an increase inridge; p, posterior; v, ventral; ef, eye field; mid, midline; ppe, pri-
mordial pigment epithelium; pe, pigment epithelium. Scale bars 5 the progenitor population, as would be the case if the
300 mm (A±C, F, H, and I), 600 mm (D and E), 500 mm (G), and 100 mm eye bud were enlarged. To test whether XOptx2 overex-
(J±M). pression affected the eye primordium, we first examined
Rx1 expression. Rx1 is detected in the presumptive eye
as early as stage 12. Prior to stage 18, the eyecup and3F), as if the extra tissue, being constrained in the optic
retina have not yet formed, and Rx1 expression is nor-capsule, was buckled. To confirm that these enlarged
mally detected in a bilaterally symmetric band at theeyes contained folded neural retina rather than disorga-
most anterior part of the neural plate (Figure 5A; Casa-nized undifferentiated cells, we stained them with layer-
rosa et al., 1997; Mathers et al., 1997). XOptx2 increasesspecific markers. The staining pattern of the rod photo-
receptor marker rhodopsin is consistent with folding of the size of the expression domain of Rx1 on the injected
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Figure 3. XOptx2 and XOptx2HD-EnR Induce Eye Enlargement, while XOptx2HD-VP16 Reduces Eye Size
(A and B) Lateral views of an XOptx2-injected embryo. The injected side is revealed by b-galactosidase activity in light blue. The eye on the
injected side (A) is enlarged.
(C and D) Transverse mideye sections of the injected (C) and control (D) side of an XOptx2-injected embryo. Note the ectopic pigment (ep).
(E±H) XOptx2-induced retinal folding and expansion. In methylene blue±stained plastic sections (E), mild retinal folding is illustrated by
following the inner plexiform layer (ipl). Severe folding can also be observed by the staining pattern of photoreceptors visualized by rhodopsin
immunocytochemistry (F). (G and H) In more severely affected animals, the optic fissure sometimes did not close and the retina appeared
fused with the forebrain (G, arrow). Rhodopsin was also detected in the ventral forebrain region as well as within the retina itself (H).
(I and J) Lateral views of an XOptx2HD-VP16-injected embryo.
(K and L) Transverse sections of XOptx2HD-EnR- and XOptx2HD-VP16-injected embryos. Nuclei were visualized with Hoechst dye. The eye
in the XOptx2HD-EnR-injected side is enlarged, while reduced in the XOptx2HD-VP16-injected side. Scale bars 5 400 mm (A, B, G, and H)
and 200 mm (C±F, K, and L).
side in stage 17 embryos (Figures 5B and 5I). There is In vertebrates, overexpression of Pax6 has been re-
ported to increase the expression of alpha-crystalline,no apparent decrease in the expression domain on the
uninjected side when compared to control embryos. a marker for lens formation (Altmann et al., 1997). How-
ever, no effect has been noted on the formation of theNormally, in embryos older than stage 18, Rx1 expres-
sion is undetectable in the midline. However, when Xenopus retina (Altmann et al., 1997; Hirsch and Harris,
1997). In the work presented here, we also found thatXOptx2 is expressed in this region, Rx1 expression re-
mains strong in the midline between the eyes of injected Pax6 alone did not affect retina formation (see below).
Consistent with these results, we found that overexpres-embryos (Figure 5D). Rx1 expression was not altered
in b-gal-injected embryos (Figure 5A) or when XOptx2 sion of Pax6 did not affect the Rx1, ET, or XOptx2 expres-
sion patterns (Figures 5I and 5J) even at doses fouroverexpression was distant from the eye field (not
shown), indicating that XOptx2, unlike Six3 (Loosli et al., times that of XOptx2.
1999), does not appear to initiate Rx1 expression.
We found that overexpression of XOptx2 also in- Pax6 Potentiates the Effects of XOptx2 on Eye
and Brain Sizecreased the domain of expression of Pax6 and ET within
the eye field at stage 17 (Figures 5C, 5F, and 5J). ET is In Drosophila, sine oculis physically interacts with eyes
absent through the Six domain, and together they canexpressed in both the eye field and the cement gland
(Figure 5F). XOptx2 differentially regulates ET expres- induce ectopic compound eye formation (Pignoni et al.,
1997). We wondered if similar synergistic effects mightsion in these two domainsÐsimultaneously increasing
ET expression in the eye field and decreasing it in the be observed in vertebrate eye development. We there-
fore overexpressed XOptx2 and XPax6 in Xenopus em-cement gland (Figure 5F). We do not know the signifi-
cance of this downregulation, as the cement gland ap- bryos by RNA injection. XPax6 alone had no effect on
eye or brain size at concentrations as high as 60 pg perpeared to form normally in older embryos.
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embryo (not shown). However, at doses as low as 2.5
pg, XPax6 potentiates the effect of XOptx2 on eye en-
largement (Figure 6A). XPax6 also potentiates the effect
of XOptx2 at higher concentrations where the enlarged
brain phenotype predominates. Greater than 15 pg of
XOptx2 is required to induce brain enlargement. How-
ever, when equal quantities of XPax6 and XOptx2 are
coinjected, as little as 10 pg of XOptx2 induces brain
enlargement (Figure 6B).
XOptx2 Acts Like a Transcriptional Repressor
In Xenopus, a species in which gene knockouts are not
yet an option, functional characterization of transcrip-
tion factors has been accomplished using activator and
repressor domain fusions (Ryan et al., 1996). We there-
fore fused the homeodomain of XOptx2 to the Engrailed
(EnR) repressor domain, creating XOptx2HD-EnR. Be-
cause the homeodomain of XOptx2 is so similar to the
homeodomain of Six3, we also fused the entire coding
sequence of XOptx2 to the Engrailed repressor domain,
creating XOptx2-EnR. When overexpressed by injection
of RNA into a single blastomere, XOptx2HD-EnR caused
a similar phenotype to XOptx2 alone, that is, an enlarge-
ment of the eye at low dose (n 5 12 of 12; Figure 3K)
and brain enlargement at high doses (n 5 18 of 18; not
shown). Similar results were obtained with XOptx2-EnR.
To test specificity directly, we injected the Engrailed
repressor RNA alone. This had no effect on embryos,
and eyes expressing EnR appeared normal. We used in
situ hybridization to determine the effect of XOptx2HD-
EnR on Rx1 expression. XOptx2HD-EnR increased the
domain of expression of Rx1 in a manner similar to that
observed in XOptx2-overexpressing embryos (Figures
5G and 5I).
Interference with XOptx2 Function
Because XOptx2 functions like a repressor, we reasoned
that conversion of its repressor function into an activator
function might result in an antimorphic phenotype simi-
lar to a knockout. Therefore, we fused the activation
domain of VP16 (Mariani and Harland, 1998) to the ho-
meodomain of XOptx2, creating XOptx2HD-VP16. Over-
expression of as little as 25 pg of XOptx2HD-VP16 in
Xenopus embryos dramatically reduced and sometimes
eliminated eye formation on the injected side of the
animal (Figures 3I, 3J, and 3L). The severity of the pheno-
type increased in a dose-dependent manner. In con-Figure 4. XOptx2-Induced Brain Enlargement and Extra Proliferation
trast, neither VP16 nor XOptx2HD alone affected eyeLow doses of XOptx2 induced mild brain enlargement anterior (A)
formation at doses as high as 500 pg. We also deter-and posterior (B) to the central retina. The retina was often expanded
mined the effect of XOptx2HD-VP16 on Rx1 expression.into the optic stalk area (A), and ectopic pigment (ep) was sometimes
observed (B). At high dose, XOptx2 induced brain enlargement (C). The domain of expression of Rx1 (and therefore the size
The enlarged side of the embryo expressed both the tracer, GFP of the eye bud) was significantly reduced on the injected
(D), and the neural marker, b-tubulin (E). The eye was often rotated side (Figures 5H and 5I).
out of its normal position by the extra neural tissue (E, arrow).
(F and G) Transverse section of an embryo injected at the 2-cell
Extra Proliferation Drives Enlargementstage with XOptx2 RNA and then injected at stage 34 with BrdU.
(F) Nuclei were visualized with Hoechst dye. (G) BrdU uptake is Two distinct but nonexclusive mechanisms could ex-
visualized in green. More BrdU-positive cells are seen on the injected plain the XOptx2-dependent increase in eye size. First,
side of the neural tube than on the control side (arrows). uncommitted cells not destined to be eye cells might
(H and I) Transverse sections of tailbud embryos injected with 2 ng be induced to change their fate to the eye cell lineage.
GFP/1 ng of b-gal RNA (H) or 1 ng of cyclin A2 RNA/1 ng of CDK2
This kind of cell fate conversion is common with overex-RNA and 1 ng of b-gal RNA (I). The injected region is revealed by
pression-induced enlargements of the nervous systemdetection of b-galactosidase activity in blue. Arrow denotes region
of epidermal thickening. Scale bars 5 200 mm (A, C±E), 65 mm (B), in Xenopus embryos (Coffman et al., 1993; Turner and
100 mm (F and G), and 150 mm (H and I). Weintraub, 1994; Lee et al., 1995). Second, cells already
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destined to form an eye may have increased mitotic
activity and therefore increase the number of cells in
the optic vesicle and eye proper.
One way to determine if XOptx2 causes extra cell
divisions in eye field cells is the analysis of cell number
in clones overexpressing this gene. We therefore cotrans-
fected retinal cells of stage 17 embryos in vivo with
XOptx2 DNA and the tracer GFP or vector only and
GFP. Transfected cells were detected by fluorescence
in cryostat-sectioned eyes of stage 41 embryos. Al-
though we cannot confirm that single cells were initially
transfected, there is reason to suspect that such clusters
have clonal origins: (1) the clusters tended to be com-
pact, oriented in vertical columns, and contained all cell
types, as is found when single cells are injected with
fluorescent or enzymatic lineage tracers; and (2) when
low doses of DNA were injected, about half the eyes
had no transfected cells, implying a Poisson distribution
of hits, yet the average number of cells in a cluster did
not decrease when the hit frequency was very low. To
increase the probability that we were examining true
clones, we minimized the amount of DNA lipofected so
that most retinas contained either no transfected cells
or single ªclones.º Second, when more than one cluster
was detected in transfected retinas, they were scored
only if the clusters were well separated.
Interestingly, XOptx2 had no effect on the relative
proportion of cell types generated from transfected cells
in these clones (Figure 7A). This result implies that
XOptx2 does not influence retinal cell fate per se. How-
ever, XOptx2 nearly doubled the number of GFP-positive
cells in retinal clones (Figures 7B±7D). The average clone
size in XOptx2-transfected retinas was 16.1 cells per
retinal section, while the cell number observed in con-
trol-expressing clones was 10.4. These results indicate
that XOptx2 induces proliferation.
Figure 5. Effect of XOptx2, XOptx2HD-EnR, and XOptx2HD-VP16
on the Expression of Transcription Factors Involved in Eye Forma-
tion and Neural Differentiation
Embryos were coinjected with XOptx2 (B±F), XOptx2HD-EnR (G), or
XOptx2HD-VP16 (H) and the tracer b-gal. After staining with X-gal
to visualize the domain of expression, in situ hybridization was used
to detect Rx1 (A, B, D, G, and H), Pax6 (C), ET (F), and b-tubulin (E)
expressions. b-gal had no effect on Rx1 expression (A). The domain
of Rx1 expression was expanded in XOptx2-injected embryos (B
and D). XOptx2 induced the expression of Rx1 across the midline
(arrow) into the optic stalk/ventral forebrain region (D). XOptx2 en-
larged the boundary of Pax6 expression (C, arrows). XOptx2 simulta-
neously induces ET expression in the eye field (F, arrows) and inhib-
its it in the developing cement gland (F, arrowhead). XOptx2 delays
the expression of b-tubulin (E, stage 22). The domain of Rx1 expres-
sion was expanded in XOptx2HD-EnR-injected embryos (G) and
decreased in XOptx2HD-VP16-injected embryos (H). Scale bar 5
300 mm. Additional abbreviations: sc, spinal cord; tg, trigeminal
ganglia.
(I and J) The percent of embryos with an increase (%↑), decrease
(%↓), or no change (% nc) in expression is shown. (I) XOptx2 and
XOptx2HD-EnR increased the domain of Rx1 expression, while
XOptx2HD-VP16 reduced it. (J) Overexpression of XOptx2 caused
an increase in the expression domain of Pax6 and ET. The majority
of embryos injected with Pax6 had no change in XOptx2 or ET
expression. Overexpression of XOptx2 also delays the expression
of b-tubulin in early-stage (prior to stage 33/34) embryos. At later
stages, an increase in b-tubulin expression is observed. Embryos
analyzed: a, 196; b, 53; c, 36; d, 11; e, 7; f, 23; g, 28; h, 56; i, 55; j,
44; k, 14; l, 43; and m, 54.
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While XOptx2 induces an eye field expansion in 75% of
the untreated injected embryos, HU treatment inhibited
the XOptx2-induced increase in eye field size in two
independent experiments (Figure 7D). In these cases,
only 17% and 11% of XOptx2-injected embryos showed
slightly enlarged eye fields when cultured in HU, and
even more showed slightly reduced eye fields (Fig-
ure 7D).
Another possible explanation for the increase in eye
size is that XOptx2 inhibits apoptosis. We therefore la-
beled embryos injected with XOptx2 mRNA in one blas-
tomere and examined cell death by TUNEL (TdT-mediated
dUTP-biotin nick end labeling) assay in the overexpress-
ing and normal retina. Instead of finding fewer apoptotic
figures in XOptx2-overexpressing eyes, we found nearly
twice as many (injected eye, 298, vs. control eye, 157;
n 5 6). These data obviously do not support the hypothe-
sis that XOptx2 is antiapoptotic and rather suggest
that we may be underestimating the hyperproliferation
caused by its overexpression.
We observed a delay in the expression of neural
b-tubulin in the brains of XOptx2-injected embryos (Fig-
ures 5E and 5J). Although expression of b-tubulin was
delayed in early-stage embryos, late-stage embryos
showed a significant increase in b-tubulin expression,
as one would expect with the enlarged brain size (Fig-
ures 4E and 5J). The delay in the expression of such aFigure 6. Pax6 Potentiates the Effect of XOptx2 on Eye and Brain
differentiated marker is consistent with extra prolifera-Enlargement
tion of neuroblasts before terminal differentiation.Embryos were injected with increasing amounts of Pax6, XOptx2,
Together, our results imply that the XOptx2-inducedor both at a 1:1 ratio. Pax6 had no effect on eye (A) or brain (B) size
at any amount tested (up to 60 pg; not shown). XOptx2 induced increase in eye size is primarily due to increased prolifer-
maximal eye enlargement at approximately 5 pg (A) and maximal ation. We therefore wished to test whether any stimula-
brain enlargement at approximately 20 pg (B). Coinjection of Pax6 tor of cell cycle progression would have similar effects
with XOptx2 potentiates the XOptx2-induced increase in both eye
on the developing eye. Cells in culture and in Drosophilaand brain size. Asterisks in (A) indicate significance: p , 0.005
embryos that overexpress cyclin A, an activator of(Student's one-tailed t test).
cyclin-dependent kinase 2 (CDK2), show precocious en-
try into S phase (Resnitzky et al., 1995; Rosenberg et al.,
1995; Sprenger et al., 1997). Therefore, RNA encodingTo test this hypothesis further, we labeled dividing
Xenopus cyclin A2 was injected into a single blastomerecells with BrdU after injecting one blastomere with
of 2-cell Xenopus embryos in combination with RNAXOptx2 RNA and allowing the embryo to develop to
encoding Xenopus CDK2. GFP RNA was injected as astage 30, when cell division in the neuroepithelium is
control, and b-gal mRNA was also added as a tracer.restricted to the ventricular surface of the neural tube.
Using methods described in Philpott et al. (1997), immu-Because of the well-organized ventricular zone in the
noprecipitation of CDK2 from extracts of injected em-brain, we focused our analysis on XOptx2-overexpress-
bryos shows a substantial increase in H1 kinase activitying embryos with enlarged brains. Nearly twice as many
(data not shown). Overexpression of cyclin A2 and CDK2BrdU-positive cells were detected in the brain on the
had pleiotropic effects on the injected side only, includ-XOptx2-injected side (n 5 4 embryos). Surprisingly, this
ing subtle enlargements of the neural tube as well aslabeling was no longer restricted to the ventricular sur-
disruption of muscle patterning. Most strikingly, 85% offace but included cells close to the pial surface, as
injected embryos showed thickening and bulges of thethough cell division was misregulated in these regions
epidermis in the most highly expressing regions (n 5(Figure 4G).
56). These areas were up to four cell layers thick insteadIf XOptx2 induces an increase in the size of the eye
of the normal two (Figure 4I). Cyclin A2 and CDK2 over-field by stimulating cell proliferation, then reagents such
expression did not, however, increase eye size.as hydroxyurea (HU) (Harris and Hartenstein, 1991) that
inhibit mitosis should block eye field enlargement. When
this test is applied to genes whose overexpression is Discussion
presumed to convert cellular fates, antimitotic agents
did not block the relative enlargement of the tissue in We propose that Optx2 is an important early regulator
of vertebrate retinal development and likely acts withquestion (Coffman et al., 1993; Turner and Weintraub,
1994). Therefore, we injected XOptx2 RNA into 2-cell other transcription factors to regulate retinal cell prolifer-
ation. This hypothesis is supported by the following fiveembryos, and at stage 11, when the eye field has not
yet formed, the injected embryos were cultured in 20 points: (1) Optx2 is highly conserved among vertebrates;
(2) XOptx2 overactivity leads to eye enlargement, whilemM HU. At stage 22, they were analyzed for eye field size
changes by determining the extent of Rx1 expression. interference with XOptx2 function reduces eye size; (3)
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XOptx2 in the Proliferative Retina
XOptx2 is expressed during the early stages of eye de-
velopment in all tissues that will give rise to the mature
retina and optic stalk. The expression patterns of Xeno-
pus Optx2 are strikingly similar to chicken and mouse
Optx2 (Toy et al., 1998; LoÂ pez-RõÂos et al., 1999; Toy and
Sundin, 1999). In the chicken, Optx2 overexpression in
pigment epithelial cells in vitro activates the expression
of retinal markers and causes the cells to assume a
neuronal morphology (Toy et al., 1998). Our data support
a proliferative but not a transdeterminative role for
XOptx2 in vivo. These results may not be inconsistent,
since transdetermination to neural retina is also ob-
served when pigment epithelial cells are induced to pro-
liferate in culture by exposure to bFGF (Pittack et al.,
1991; Sakaguchi et al., 1997). The pattern of XOptx2
expression mimics changes in the expression patterns
of Xenopus Pax6, Rx1, and ET and is consistent with
the hypothesis that vertebrate eyes develop from a sin-
gle eye field that subsequently separates into two dis-
tinct eye fields (Casarosa et al., 1997; Hirsch and Harris,
1997; Li et al., 1997; Mathers et al., 1997). Studies of
cell proliferation in the anterior neural plate have shown
that the eye fields, and later the optic vesicles, have
particularly high mitotic indices (Eagleson et al., 1995).
The expression patterns of XOptx2, Pax6, Rx1, and ET
are overlapping during early eye development but are
quite different in the mature Xenopus retina (Li et al.,
1997; Perron et al., 1998). These differences in expres-
sion patterns may imply a requirement for these tran-
scription factors in the maintenance of the diverse cell
types of the adult eye.
It may seem surprising that an increase in eye size is
possible without conversion of fate in a Xenopus embryo
in which, because the embryo has holoblastic cleavage
and distributed yolk, cell size decreases with every divi-
sion. Indeed, blocking cell division in the neural plate
stage embryo using HU results in eyes with large cells
(Harris and Hartenstein, 1991). HU-treated eyes are nev-
ertheless smaller than normal, indicating that organ size
depends on proliferation as well. Since yolk is concen-
trated in the gut and depleted from this store duringFigure 7. XOptx2 Promotes Cell Proliferation in Retinal Lipofection
Experiments and Eye Field Enlargement Is Dependent on Cellular embryogenesis, it is possible that rapidly growing tis-
Proliferation sues, like the eye, may have access to a disproportion-
(A) Percentage of retinal cell types observed in eyes lipofected with ate amount of this gut yolk. The cells in XOptx2-enlarged
GFP/pCS2 or GFP/XOptx2. We combined here the data from two eyes had normal diameters (data not shown), suggesting
independent experiments. XOptx2 transfection produced no signifi-
that in spite of their extra proliferation they were ablecant change in cell type distribution. The percentage of each cell
to grow to normal size.type was calculated as a weighted average per retina.
(B) Histogram showing the percentage of clones according to the In the mature retina, XOptx2 is expressed in the CMZ,
number of transfected cells per section in GFP/pCS2- and GFP/ in which retinal cells continue to divide throughout the
XOptx2-transfected retina. The number of cells per clone was calcu- life of the animal. Therefore, by its temporal and spatial
lated as a weighted average per retina. Again, we combined the
expression pattern, XOptx2 is strategically positioneddata from two independent experiments. XOptx2 (average of 16.1
to play a major role in cellular proliferation in the embry-cells per section) produced significantly larger clones than control
onic eye and the growing larval eye. XOptx2 possessesconstructs (10.4 cells per section).
(C) Representative retinal sections from GFP/pCS2 (left, 10 cells) and a specificity with respect to its ability to stimulate retinal
GFP/XOptx2 (right, 20 cells) transfected retina. Scale bar 5 50 mm. cell proliferation. A number of different cell cycle genes,
(D) XOptx2 induced an eye field expansion. HU treatment inhibited including cyclins (cyclin D1 in particular), CDKs, CDK
the XOptx2-induced expansion. Embryos analyzed: a, 53; b, 75.
inhibitors, and rb, are expressed in retinoblasts, so it
will be useful to investigate the relationship between
XOptx2 and these genes in future studies. Our cyclinXOptx2 is normally expressed in the eye; (4) overexpres-
A2 and CDK2 experiments imply that different tissuession of XOptx2 increases proliferation of neural cells;
respond differently to overexpression of selected com-and (5) Pax6 and XOptx2 act synergistically on eye for-
mation. ponents of the cell cycle machinery.
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XOptx2 in the Context of Other Eye Genes: Pax6, Pax6 physically interact, are consistent with the pro-
posal that coexpression of these genes is importantRx1, Six3, and ET
during the development of the vertebrate eye.The expression of Pax6, Rx1, and ET is apparently earlier
The ability of XOptx2, an intrinsic retinal transcriptionthan XOptx2, implying a potential genetic cascade in
factor, to regulate eye size by driving proliferation raiseswhich Optx2 is downstream of these other eye field
the question of whether other transcription factors, likegenes or has a slightly later role in eye formation.
Optx2 but expressed in different embryonic domains atWe propose that XOptx2 expands the eye field domain
different times, have similar roles in the intrinsic regula-not by conversion of cells to the eye fate but by extra
tion of organ size.divisions of cells in the region of the embryo that already
expresses early eye determinant genes (Pax6, Rx1, or
Experimental ProceduresET). XOptx2 expression did not induce ectopic expres-
sion of these genes distant from the eye field, nor did it Isolation and Analysis of the XOptx2 cDNA
induce ectopic eye formation. Hyperplasia of the rostral A 489 bp fragment of the XOptx2 cDNA was RT-PCR amplified using
forebrain and retina has been seen in fish embryos mis- RNA isolated from stage 18 Xenopus. This fragment was used as a
probe to isolate eight additional clones from a stage 17 lgt11 cDNAexpressing the Six3 gene (Kobayashi et al., 1998; Loosli
library. 59-RACE was used to isolate additional 59 sequenceset al. 1999). Whether this is caused by extra proliferation
(GIBCO-BRL). Analysis of the DNA and protein sequences was per-or transformation of the affected tissues has not been
formed using the Lasergene Software package (DNASTAR, Madi-
investigated. Unlike XOptx2, Six3 misexpression also son, WI). XOptx2 cDNA was subcloned into the vector pCS2 (pro-
initiates the formation of ectopic eye markers, sug- vided by D. Turner) to create pCS2.XOptx2.
gesting that conversion of fate, rather than proliferation,
Repressor/Activator Constructsis the mechanism (Loosli et al., 1999). Nevertheless,
To generate pCS2.XOptx2-EnR, nucleotides 247 to 1096 of thethe strong similarities in sequence and overexpression
XOptx2 cDNA (Figure 1A) were PCR amplified using primers Opt-
phenotypes between XOptx2 and Six3 indicate that x2EngRf1 59TCGAATTCCGTGCAGCCAGAGATC39 and Optx2EngRr1
these genes may act in concert or by similar mecha- 59GGAATTCCGATGTCACATTCACTGTCGCT39, digested with EcoRI,
and cloned into the EcoRI site of pCS2.ENG-N. pCS2XOptx2HD-nisms. Once the Six3 gene is isolated in Xenopus, it will
EngR and pCS2NLSXOptx2HD-VP16 were created by first PCRbe possible to compare the functions of these two genes
amplifying nucleotides 724 to 944 of XOptx2 using the primersdirectly. At later stages, expression of late retinal mark-
OHDEngRf1 59GGAATTCCGCCATGGCCAGAACTATTTGGGACGGG39,
ers such as rhodopsin were also detected in the ventral OHDEngRr1 59GGAATTCCCTGTAGCCTGTTCTTTGCCGC39, NOHD
forebrain region, suggesting that retinal tissue had in- VP1659 59GGAATTCCAGAACTATTTGGGACGGG39, and NOHDVP
vaded this territory. In the dorsal brain, however, where 1639 59GGAATTCCGCTGTAGCCTGTTCTTTGCCGC39. The XOptx
2HDs were cloned into the EcoRI sites of pCS2.ENG-N and pCS2the eye determination genes are not normally ex-
NLSVP16 to create pCS2XOptx2HD-EngR and pCS2NLSXOptx2HD-pressed, high doses of XOptx2 induced brain enlarge-
VP16, respectively.ment but not retinal markers. The enlarged tissue pheno-
type was restricted to neural tissue, suggesting that Animals
additional competence factors present in neural tissue Fertilized eggs were obtained from pigmented and albino Xenopus
injected with 500 U of human chorionic gonadotropin (Sigma) toor negative factors expressed elsewhere are required
induce egg laying. Embryos were dejellied in 2% cysteine (pH 8.0).for differential sensitivity to XOptx2.
Embryos were staged according to Nieuwkoop and Faber (1994).Coexpression of Pax6 potentiates the XOptx2-depen-
dent effects on eye and brain enlargement. Xenopus RNA Microinjection and Hydroxyurea Treatment
embryos injected with 200 pg of Rx1 RNA also show Capped RNA was synthesized in vitro from pCS2.XOptx2,
pCS2.Pax6, pCS2.XOptx2-EngR, pCS2XOptx2OHD-EngR, pCS2NLectopic RPE formation and a partial duplication of the
SXOptx2HD-VP16 pCS2.MTXcyclinA2, pCS2.MTXcdk2, pCS2.nucb-retina (Mathers et al., 1997). This is similar but not identi-
gal, or pCS2.GFP template DNA using a Message Machine kit (Am-cal to the phenotype induced by as little as 5 pg of
bion). X-gal staining was performed on embryos injected with b-gal
XOptx2 RNA, which also increases XRx1 expression. as previously described (Turner and Weintraub, 1994). For the HU
Thus, it may also be fruitful to investigate a possible experiments, stage 11 XOptx2-injected embryos were incubated in
synergy between these two genes. Alternatively, other 20 mM HU (Sigma) and 0.13 MMR until stage 22 prior to in situ
hybridization.as yet unidentified genes are potential candidates for the
eye and brain factors that allow tissue in these regions to
Quantitation of Enlarged Eye and Brain Phenotypesrespond to XOptx2. Embryos injected for phenotypic analysis were grown to stage 35
Recent work in Drosophila and vertebrates has dem- or 36 and fixed in 4% paraformaldehyde in 0.1 M phosphate buffer
onstrated that eye formation relies on the timely action at room temperature for 1 hr. The eye diameters were measured
and used to calculate the percent increase in eye diameter on theof transcription factors expressed in the eye field and
injected side of each embryo. In Figure 6, the average increase induring early retinal development. The transcription fac-
eye diameter for each treatment was calculated using at least 40tors eyeless and daschund can generate ectopic eyes
embryos. Similar results were obtained in two independent experi-
in fly (Halder et al., 1995; Shen and Mardon, 1997), as ments. Embryos were considered to display the enlarged brain phe-
can sine oculis and eyes absent when coexpressed (Pig- notype if a definitive bulge in the eye region was detected and the
eye was either not visible or rotated out of its normal position.noni et al., 1997). To date, there has been no report of
a single gene or combination of genes sufficient for
BrdU Immunodetectionthe formation of complete ectopic eyes in a vertebrate
For BrdU labeling, embryos were anesthetized with MS-222 in 0.13
species. In this study, we show that Pax6 potentiates the MBS and injected with undiluted BrdU labeling reagent (Boehringer
XOptx2 effect on eye size. The experiments performed Mannheim, BrdU labeling and detection kit I) in the yolk. Immediately
after injection, embryos were transferred to 0.13 MBS for 3 hr andhere, although they in no way suggest that XOptx2 and
Giant Eyes in Xenopus
351
then fixed for 2 hr in 4% paraformaldehyde and paraffin sectioned Dorsky, R.I., Rapaport, D.H., and Harris, W.A. (1995). Xotch inhibits
cell differentiation in the Xenopus retina. Neuron 14, 487±496.(10 mm). Rehydrated sections were rinsed with PBS, incubated 45
min in 2 N HCl, and rerinsed with PBS prior to BrdU immunodetection Eagleson, G., Ferreiro, B., and Harris, W.A. (1995). Fate of the anterior
per manufacturer's instructions. neural ridge and the morphogenesis of the Xenopus forebrain. J.
Neurobiol. 28, 146±158.
In Situ Hybridization and Immunocytochemistry Halder, G., Callaerts, P., and Gehring, W.J. (1995). Induction of ec-
Digoxigenin (DIG)-labeled antisense RNA probes were generated topic eyes by targeted expression of the eyeless gene in Drosophila.
for XOptx2, Rx1 (Casarosa et al., 1997), Pax6 (Hirsch and Harris, Science 267, 1788±1792.
1997), ET (Li et al., 1994), and N-tubulin (Richter et al., 1988) as Halder, G., Callaerts, P., Flister, S., Walldorf, U., Kloter, U., and
described in Harland (1991). Whole-mount in situ hybridization was Gehring, W.J. (1998). Eyeless initiates the expression of both sine
performed on albino Xenopus embryos using the procedure de- oculis and eyes absent during Drosophila compound eye develop-
scribed in Harland (1991). In situ hybridizations on 10 mm cryostat ment. Development 125, 2181±2191.
sections of Xenopus embryos were done as described in Kanekar
Harland, R.M. (1991). In situ hybridization: an improved whole-mountet al. (1997). Immunohistochemistry was performed using an anti-
method for Xenopus embryos. Methods Cell Biol. 36, 685±695.rod opsin antibody diluted 1:100 using methods described pre-
Harris, W.A. (1979). Amphibian chimeras and the nervous system.viously (Turner and Weintraub, 1994). The primary antibody was
Soc. Neurosci. Symp. 4, 228±257.detected with a rhodamine-conjugated goat anti-mouse antibody
(Sigma) diluted 1:100. Harris, W.A., and Hartenstein, V. (1991). Neuronal determination
without cell division in Xenopus embryos. Neuron 6, 499±515.
Hirsch, N., and Harris, W.A. (1997). Xenopus Pax-6 and retinal devel-In Vivo DNA Lipofection
opment. J. Neurobiol. 32, 45±61.DNA was transfected into the presumptive region of the retina of
stage 18 embryos as previously described (Holt et al., 1990; Dorsky Holt, C.E., Garlick, N., and Cornel, E. (1990). Lipofection of cDNAs
et al., 1995). GFP DNA was cotransfected to label-transfected cells. in the embryonic central nervous system. Neuron 4, 203±214.
Embryos were fixed at stage 40±41 and cryostat sectioned (10 mm). Jean, D., Ewan, K., and Gruss, P. (1998). Molecular regulators in-
GFP-positive cells were counted and cell types identified based volved in vertebrate eye development. Mech. Dev. 76, 3±18.
on their laminar position and morphology, as previously described
Kanekar, S., Perron, M., Dorsky, R., Harris, W.A., Jan, L.Y., Jan, Y.N.,(Dorsky et al., 1995).
and Vetter, M.L. (1997). Xath5 participates in a network of bHLH
genes in the developing Xenopus retina. Neuron 19, 981±994.
Cell Counts
Kobayashi, M., Toyama, R., Takeda, H., Dawid, I.B., and Kawakami,
Transverse sections of GFP- and XOptx2-injected embryos were
K. (1998). Overexpression of the forebrain-specific homeobox gene
stained with Hoechst dye (0.5 mg/ml, Sigma) to visualize nuclei. six3 induces rostral forebrain enlargement in zebrafish. Develop-
Images were taken under UV fluorescence and the number of nuclei ment 125, 2973±2982.
counted on both injected (identified by GFP fluorescence) and unin-
Lee, J.E., Hollenberg, S.M., Snider, L., Turner, D.L., Lipnick, N., andjected sides using Adobe Photoshop software.
Weintraub, H. (1995). Conversion of Xenopus ectoderm into neurons
by NeuroD, a basic helix-loop-helix protein. Science 268, 836±844.
Apoptosis Assays
Li, H., Tierney, C., Wen, L., Wu, J.Y., and Rao, Y. (1997). A singleApoptotic cells were detected using the Apoptosis Detection Sys-
morphogenetic field gives rise to two retina primordia under thetem as specified by the manufacturer (Promega).
influence of the prechordal plate. Development 124, 603±615.
Loosli, F., Winkler, S., and Wittbrodt, J. (1999). Six3 overexpression
Acknowledgments
initiates the formation of ectopic retina. Genes Dev. 13, 649±654.
LoÂ pez-RõÂos, J., Gallardo, M.E., RodriÂguez de CoÂ rdoba, S., and Bovo-We would like to thank M. Andreazzoli, Y. Rao, T. Hunt, K. Wang,
lenta, P. (1999). Six9 (Optx2), a new member of the Six gene familyN. Papalopulu, and N. Colley, who provided us with the Rx1 and
of transcription factors, is expressed at early stages of vertebratepCS2EngR, ET, cyclin A2, CDK2, nucb-gal constructs and the anti-
ocular and pituitary development. Mech. Dev. 83, 155±159.rhodopsin antibody, respectively. We would also like to thank Chris
Mardon, G., Solomon, N.M., and Rubin, G.M. (1994). DachshundBond, Lianna Ishihara, Andrea Viczian, and Susannah Hopper for
encodes a nuclear protein required for normal eye and leg develop-technical assistance. The Wellcome Trust and an EC Biotechnology
ment in Drosophila. Development 120, 3473±3486.Grant supported this work. The Burroughs Wellcome Fund through
a Hitchings-Elion fellowship and a Marie Curie EC fellowship support Mariani, F.V., and Harland, R.M. (1998). XBF-2 is a transcriptional
M. E. Z. and M. P., respectively. repressor that converts ectoderm into neural tissue. Development
125, 5019±5031.
Received January 13, 1999; revised June 7, 1999. Mathers, P.H., Grinberg, A., Mahon, K.A., and Jamrich, M. (1997).
The Rx homeobox gene is essential for vertebrate eye development.
Nature 387, 603±607.References
Nieuwkoop, P.D., and Faber, J. (1994). Normal Table of Xenopus
laevis (New York: Garland Publishing, Inc.).Altmann, C.R., Chow, R.L., Lang, R.A., and Hemmati-Brivanlou, A.
(1997). Lens induction by Pax-6 in Xenopus laevis. Dev. Biol. 185, Oliver, G., Loosli, F., Koster, R., Wittbrodt, J., and Gruss, P. (1996).
119±123. Ectopic lens induction in fish in response to the murine homeobox
gene Six3. Mech Dev. 60, 233±239Bonini, N.M., Leiserson, W.M., and Benzer, S. (1993). The eyes ab-
sent gene: genetic control of cell survival and differentiation in the Perron, M., Kanekar, S., Vetter, M.L., and Harris, W.A. (1998). The
developing Drosophila eye. Cell 72, 379±395. genetic sequence of retinal development in the ciliary margin of the
Xenopus eye. Dev. Biol. 199, 185±200.Casarosa, S., Andreazzoli, M., Simeone, A., and Barsacchi, G. (1997).
Xrx1, a novel Xenopus homeobox gene expressed during eye and Philpott, A., Porro, E.B., Kirschner, M.W., and Tsai, L.H. (1997). The
pineal gland development. Mech. Dev. 61, 187±198. role of cyclin-dependent kinase 5 and a novel regulatory subunit in
regulating muscle differentiation and patterning. Genes Dev. 11,Cheyette, B.N., Green, P.J., Martin, K., Garren, H., Hartenstein, V.,
1409±1421.and Zipursky, S.L. (1994). The Drosophila sine oculis locus encodes
a homeodomain-containing protein required for the development of Pignoni, F., Hu, B., Zavitz, K.H., Xiao, J., Garrity, P.A., and Zipursky,
the entire visual system. Neuron 12, 977±996. S.L. (1997). The eye-specification proteins So and Eya form a com-
plex and regulate multiple steps in Drosophila eye development.Coffman, C.R., Skoglund, P., Harris, W.A., and Kintner, C.R. (1993).
Cell 91, 881±891. Erratum: Cell 92(4), 1998.Expression of an extracellular deletion of Xotch diverts cell fate in
Xenopus embryos. Cell 73, 659±671. Pittack, C., Jones, M., and Reh, T.A. (1991). Basic fibroblast growth
Cell
352
factor induces retinal pigment epithelium to generate neural retina
in vitro. Development 113, 577±588.
Quiring, R., Walldorf, U., Kloter, U., and Gehring, W.J. (1994). Homol-
ogy of the eyeless gene of Drosophila to the Small eye gene in mice
and Aniridia in humans. Science 265, 785±789.
Resnitzky, D., Hengst, L., and Reed, S.I. (1995). Cyclin A-associated
kinase activity is rate limiting for entrance into S phase and is nega-
tively regulated in G1 by p27Kip1. Mol. Cell. Biol. 15, 4347±4352.
Richter, K., Grunz, H., and Dawid, I.B. (1988). Gene expression in
the embryonic nervous system of Xenopus laevis. Proc. Natl. Acad.
Sci. USA 85, 8086±8090.
Rosenberg, A.R., Zindy, F., Le Deist, F., Mouly, H., Metezeau, P.,
Brechot, C., and Lamas, E. (1995). Overexpression of human cyclin
A advances entry into S phase. Oncogene 10, 1501±1509.
Rotmann, E. (1939). Der Anteil von Inductor und reagierendem Ge-
webe an der Entwicklung der Amphibienlinse. Wilhelm Roux' Arch.
Entwicklungsmech. Org. 139, 1±49.
Rotmann, E. (1940). Die Bedeuting der ZellgroÈ sse fuÈ r die Entwicklung
der Amphibienlinse. Wilhelm Roux' Arch. Entwicklungsmech. Org.
140, 124±156.
Ryan, K., Garrett, N., and Gurdon, J. (1996). Eomesodermin, a key
early gene in Xenopus mesoderm differentiation. Cell 87, 989±1000.
Sakaguchi, D.S., Janick, L.M., and Reh, T.A. (1997). Basic fibroblast
growth factor (FGF-2) induced transdifferentiation of retinal pigment
epithelium: generation of retinal neurons and glia. Dev. Dyn. 209,
387±398.
Shen, W., and Mardon, G. (1997). Ectopic eye development in Dro-
sophila induced by directed dachshund expression. Development
124, 45±52.
Sprenger, F., Yakubovich, N., and O'Farrell, P.H. (1997). S-phase
function of Drosophila cyclin A and its downregulation in G1 phase.
Curr. Biol. 7, 488±499.
Stone, L.S. (1930). Heteroplastic transplantation of eyes between
larvae of two species of Amblystoma. J. Exp. Zool. 55, 193±261.
Toy, J., and Sundin, O.H. (1999). Expression of the Optx2 homeobox
gene during mouse development. Mech. Dev. 83, 183±186.
Toy, J., Yang, J.M., Leppert, G.S., and Sundin, O.H. (1998). The
optx2 homeobox gene is expressed in early precursors of the eye
and activates retina-specific genes. Proc. Natl. Acad. Sci. USA 95,
10643±10648.
Turner, D.L., and Weintraub, H. (1994). Expression of achaete-scute
homolog 3 in Xenopus embryos converts ectodermal cells to a neu-
ral fate. Genes Dev. 8, 1434±1447.
Twitty, V.C. (1940). Size-controlling factors. Growth 4, 109±120.
Twitty, V.C. (1955). Eye. In Analysis of Development, B.H. Willier,
P.A. Weiss, and V. Hamburger, eds. (Philadelphia: W.B. Saunders),
pp. 402±414.
GenBank Accession Number
The Xenopus Optx2 nucleotide sequence has been deposited into
the GenBank database under accession number AF081352.
